Product Information

GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION is a generic product labeled by Saptalis Pharmaceuticals LLC, priced at $0.2027 per ML under NDC 71656006116. Its NADAC has been published 80 times since Feb 12, 2025.

FDA first approved this application on Oct 7, 2024. Its Orange Book therapeutic-equivalence code is AA.

GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION

glycopyrrolate
$0.2027per ML

Strength

1 mg/5mL

NDC

71656006116

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GLYCOPYRROLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA216297

FDA Approved

10/7/2024

TE Code

AA

On Market Since

11/25/2024

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists
Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has been published 80 times since Feb 12, 2025, and over the history we have for it it has declined 51.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2027 per ML
All-time high$0.4173 (Feb 12, 2025)
All-time low$0.1689 (May 20, 2026)
52-week high$0.2612
52-week low$0.1689
Median price$0.2458
Average price$0.2471
Largest weekly change-15.1% (Feb 18, 2026)
Weeks tracked80
Tracking sinceFeb 12, 2025

Price History

1W

+5.4%

1M

+5.4%

3M

+20.0%

6M

-4.2%

1Y

-22.4%

3Y

N/A

5Y

N/A

All

-51.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the glycopyrrolate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION, manufactured by Saptalis Pharmaceuticals LLC, is $0.2027 per ML (NDC 71656006116), effective Aug 19, 2026.

How has the price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION changed over time?

Over the history we have for it, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has declined 51.4%. It has been tracked across 80 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?

Since Feb 12, 2025, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has ranged from a low of $0.1689 (May 20, 2026) to a high of $0.4173 (Feb 12, 2025), with a median of $0.2458 per ML.

Are there cheaper alternatives to GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?

No other NADAC-published product currently shares the active ingredient and strength of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?

GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION (NDC 71656006116) is labeled by Saptalis Pharmaceuticals LLC, and CMS classifies it as a generic product.